Sevelamer
Back to searchMolecule Structure
Scientific Name
Sevelamer
Description of the Drug
Sevelamer is a phosphate binder used to treat hyperphosphatemia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00658
http://www.drugbank.ca/drugs/DB00658
Brand Name(s)
Renagel, Renvela
Company Owner(s)
Micro Labs Ltd, Amneal Pharmaceuticals Co Gmbh, Genzyme Corp, Impax Laboratories Inc, Anxin Pharma Inc, Invagen Pharmaceuticals Inc, Twi Pharmaceuticals Inc, Impax Laboratories Llc, Aurobindo Pharma Ltd, Dr Reddys Laboratories Ltd
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL726092 | |||
| PharmGKB | PA164781197 | |||
| DrugBank | DB00658 | |||
| PubChem: Thomson Pharma | 15194705 | |||
| PubChem | 3085017 | |||
| ChemicalBook | CB91106827 | |||
| rxnorm | RENAGEL | SEVELAMER | RENVELA | SEVELAMER CARBONATE |
